Fed. Circ. Mulls Amgen-Sandoz Psoriasis Drug Dispute

By Nadia Dreid (February 8, 2023, 8:57 PM EST) -- The Federal Circuit spend part of its morning Wednesday parsing the definition of "a difference in degree not in kind" in order to decide whether a lower court had erred by tossing out two Amgen patents covering a plaque psoriasis medication but leaving two others that create a "patent estate" around the medication....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Read the full article

Already a subscriber? Click here to login